BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 33121317)

  • 41. Nomograms for predicting cancer-specific and overall survival in patients with invasive extramammary Paget's disease.
    Gao X; Zhong X; Chen HN; Singh D; Yang L; Huang LB; Wang C; Zhou ZG
    Future Oncol; 2021 Jul; 17(21):2785-2801. PubMed ID: 33988031
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nomogram for predicting the survival of patients with small cell carcinoma of the esophagus: A population study based on the surveillance, epidemiology, and end results database.
    Qie S; Wang XF; Ran YG; Liu ML; Cui GM; Shi HY
    Medicine (Baltimore); 2021 Apr; 100(15):e25427. PubMed ID: 33847642
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identifying the Prognosis Factors and Predicting the Survival Probability in Patients with Non-Metastatic Chondrosarcoma from the SEER Database.
    Huang R; Sun Z; Zheng H; Yan P; Hu P; Yin H; Zhang J; Meng T; Huang Z
    Orthop Surg; 2019 Oct; 11(5):801-810. PubMed ID: 31663279
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nomogram for Predicting the Overall Survival of Patients With Breast Cancer With Pathologic Nodal Status N3.
    Wang J; Chen L; Nie Y; Wu W; Yao Y
    Clin Breast Cancer; 2020 Dec; 20(6):e778-e785. PubMed ID: 32636150
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development and validation of a prognostic nomogram for early-onset colon cancer.
    Yu C; Zhang Y
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31142625
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development and validation of a preoperative nomogram for predicting survival of patients with locally advanced prostate cancer after radical prostatectomy.
    Zhou X; Ning Q; Jin K; Zhang T; Ma X
    BMC Cancer; 2020 Feb; 20(1):97. PubMed ID: 32019501
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Individualized prediction of survival benefits from perioperative chemoradiotherapy for patients with resectable gastric cancer.
    Che K; Liu F; Wu N; Liu Q; Yuan L; Wei J
    Cancer Med; 2020 Oct; 9(19):7137-7150. PubMed ID: 32810384
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nomograms predict survival of patients with lymph node-positive, luminal a breast cancer.
    Li Y; Ma L
    BMC Cancer; 2021 Aug; 21(1):965. PubMed ID: 34454451
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epidemiologic Trends of and Factors Associated With Overall Survival for Patients With Gastroenteropancreatic Neuroendocrine Tumors in the United States.
    Xu Z; Wang L; Dai S; Chen M; Li F; Sun J; Luo F
    JAMA Netw Open; 2021 Sep; 4(9):e2124750. PubMed ID: 34554237
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Nomogram and a Risk Classification System Predicting the Cancer-Specific Survival of Patients With Initially-Diagnosed Osseous Spinal and Pelvic Tumors.
    Zhou Q; Li AB; Lin ZQ; Zhang HZ
    Spine (Phila Pa 1976); 2020 Jun; 45(12):E713-E720. PubMed ID: 32039945
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic Significance of Tumor Deposits in Patients With Stage III Colon Cancer: A Nomogram Study.
    Zheng P; Chen Q; Li J; Jin C; Kang L; Chen D
    J Surg Res; 2020 Jan; 245():475-482. PubMed ID: 31446189
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epidemiological features of primary breast lymphoma patients and development of a nomogram to predict survival.
    Peng F; Li J; Mu S; Cai L; Fan F; Qin Y; Ai L; Hu Y
    Breast; 2021 Jun; 57():49-61. PubMed ID: 33774459
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Establishment and validation of prognostic nomograms to predict overall survival and cancer-specific survival for patients with osteosarcoma.
    Yang QK; Lai QY; Wang Y; Wang Y; Yao ZX; Zhang XJ
    Neoplasma; 2021 Mar; 68(2):434-446. PubMed ID: 33118831
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development and validation of a prognostic nomogram for predicting cancer-specific survival after radical cystectomy in patients with bladder cancer:A population-based study.
    Yang Z; Bai Y; Liu M; Hu X; Han P
    Cancer Med; 2020 Dec; 9(24):9303-9314. PubMed ID: 33063464
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association between socioeconomic factors at diagnosis and survival in breast cancer: A population-based study.
    Ji P; Gong Y; Jiang CC; Hu X; Di GH; Shao ZM
    Cancer Med; 2020 Mar; 9(5):1922-1936. PubMed ID: 31960597
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic evaluation of esophageal cancer patients with stages I-III.
    Qiu MJ; Yang SL; Wang MM; Li YN; Jiang X; Huang ZZ; Xiong ZF
    Aging (Albany NY); 2020 Jul; 12(14):14736-14753. PubMed ID: 32701062
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk factors and predictive nomograms for early death of patients with advanced hepatocellular carcinoma: a large retrospective study based on the SEER database.
    Zhang H; Du X; Dong H; Xu W; Zhou P; Liu S; Qing X; Zhang Y; Yang M; Zhang Y
    BMC Gastroenterol; 2022 Jul; 22(1):348. PubMed ID: 35854221
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nomogram for predicting preoperative regional lymph nodes metastasis in patients with metaplastic breast cancer: a SEER population-based study.
    Zhang M; Wang B; Liu N; Wang H; Zhang J; Wu L; Zhao A; Wang L; Zhao X; Yang J
    BMC Cancer; 2021 May; 21(1):565. PubMed ID: 34001061
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nomograms-based prediction of overall and cancer-specific survivals for patients with chromophobe renal cell carcinoma.
    Chen C; Geng X; Liang R; Zhang D; Sun M; Zhang G; Hou J
    Exp Biol Med (Maywood); 2021 Mar; 246(6):729-739. PubMed ID: 33302735
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nomogram for predicting the overall survival of patients with inflammatory breast cancer: A SEER-based study.
    Pan X; Yang W; Chen Y; Tong L; Li C; Li H
    Breast; 2019 Oct; 47():56-61. PubMed ID: 31351202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.